Molflu is expected to be available from early next week in pharmacies throughout the country with a particular focus on states with a high caseload of Covid-19.
ASC10 is an oral direct-acting antiviral drug candidate targeting RNA dependent RNA polymerase (RdRp) to treat SARS-CoV-2 infection
The contract award from the U.S. Department of Defense (DoD), on behalf of the U.S. Department of Health and Human Services, is part of an effort to ensure secure local supply and production capacity for critical products for pandemic preparedness
The combination enhances Comar's customer value proposition by adding complementary closure and jar products and related precision mold-making expertise
Rapid antigen testing provides results in just 15 minutes and the information can help reduce the risk of Covid-19 exposure
Covaxin has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study. Neutralizing antibodies in children on an average 1.7 times higher than in adults
The newly launched centre in Mumbai is part of the company’s ambition to be present in 100 cities across the country within two years.”
All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval.
It plans to deliver over 300 million doses to the Indian government
The company will market it under the brand name Molflu
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
